BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 35132597)

  • 21. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.
    Wu YH; Yeh IJ; Phan NN; Yen MC; Hung JH; Chiao CC; Chen CF; Sun Z; Hsu HP; Wang CY; Lai MD
    J Microbiol Immunol Infect; 2021 Oct; 54(5):845-857. PubMed ID: 34176764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.
    Huang T; Sun L; Kang D; Poongavanam V; Liu X; Zhan P; Menéndez-Arias L
    Adv Exp Med Biol; 2021; 1322():219-260. PubMed ID: 34258743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronaviruses - a new old menace.
    Golke A; Piekarska K; Dzieciątkowski T
    Postepy Biochem; 2020 Dec; 66(4):303-308. PubMed ID: 33470077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patents Related to Pathogenic Human Coronaviruses.
    Dos Santos M; Ferreira AVF; da Silva JO; Nogueira LM; Machado JM; Francisco MFC; da Paz MC; Giunchetti RC; Galdino AS
    Recent Pat Biotechnol; 2021; 15(1):12-24. PubMed ID: 33504319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS.
    Aljabr W; Alruwaili M; Penrice-Randal R; Alrezaihi A; Harrison AJ; Ryan Y; Bentley E; Jones B; Alhatlani BY; AlShahrani D; Mahmood Z; Rickett NY; Alosaimi B; Naeem A; Alamri S; Alsran H; Hamed ME; Dong X; Assiri AM; Alrasheed AR; Hamza M; Carroll MW; Gemmell M; Darby A; Donovan-Banfield I; Stewart JP; Matthews DA; Davidson AD; Hiscox JA
    mSphere; 2021 Aug; 6(4):e0021921. PubMed ID: 34287009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact-an updated review.
    Attia YA; El-Saadony MT; Swelum AA; Qattan SYA; Al-Qurashi AD; Asiry KA; Shafi ME; Elbestawy AR; Gado AR; Khafaga AF; Hussein EOS; Ba-Awadh H; Tiwari R; Dhama K; Alhussaini B; Alyileili SR; El-Tarabily KA; Abd El-Hack ME
    Environ Sci Pollut Res Int; 2021 May; 28(18):22241-22264. PubMed ID: 33733422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19: Coronavirus Vaccine Development Updates.
    Zhao J; Zhao S; Ou J; Zhang J; Lan W; Guan W; Wu X; Yan Y; Zhao W; Wu J; Chodosh J; Zhang Q
    Front Immunol; 2020; 11():602256. PubMed ID: 33424848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach.
    Khan T; Khan A; Ansari JK; Najmi MH; Wei DQ; Muhammad K; Waheed Y
    Molecules; 2022 Apr; 27(7):. PubMed ID: 35408772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralizing monoclonal antibodies against highly pathogenic coronaviruses.
    Xiang R; Wang Y; Wang L; Deng X; Huo S; Jiang S; Yu F
    Curr Opin Virol; 2022 Apr; 53():101199. PubMed ID: 35038651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Middle East Respiratory Syndrome Coronavirus - A Continuing Risk to Global Health Security.
    Azhar EI; Lanini S; Ippolito G; Zumla A
    Adv Exp Med Biol; 2017; 972():49-60. PubMed ID: 27966107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight.
    He C; Qin M; Sun X
    Acta Pharm Sin B; 2020 Jul; 10(7):1175-1191. PubMed ID: 32834948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress.
    Kovalenko A; Ryabchevskaya E; Evtushenko E; Nikitin N; Karpova O
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review.
    Alsobaie S
    Infect Drug Resist; 2021; 14():2259-2268. PubMed ID: 34163190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ca
    Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
    Agnihothram S; Yount BL; Donaldson EF; Huynh J; Menachery VD; Gralinski LE; Graham RL; Becker MM; Tomar S; Scobey TD; Osswald HL; Whitmore A; Gopal R; Ghosh AK; Mesecar A; Zambon M; Heise M; Denison MR; Baric RS
    mBio; 2014 Mar; 5(2):e00047-14. PubMed ID: 24667706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in mRNA and other vaccines against MERS-CoV.
    Tai W; Zhang X; Yang Y; Zhu J; Du L
    Transl Res; 2022 Apr; 242():20-37. PubMed ID: 34801748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.